Alternative Data for 10X Genomics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 37 | Sign up | Sign up | Sign up |
| Sentiment | 67 | Sign up | Sign up | Sign up |
| Webpage traffic | 260,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 104 | Sign up | Sign up | Sign up |
| Facebook Followers | 15,698 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,794 | Sign up | Sign up | Sign up |
| X Followers | 28,692 | Sign up | Sign up | Sign up |
| X Mentions | 29 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 7,310 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 47 | Sign up | Sign up | Sign up |
| Linkedin Employees | 2,281 | Sign up | Sign up | Sign up |
About 10X Genomics
A life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific.
| Price | $23.00 |
| Target Price | Sign up |
| Volume | 2,118,859 |
| Market Cap | $2.94B |
| Year Range | $11.34 - $23.19 |
| Dividend Yield | 0% |
| Analyst Rating | 55% buy |
| Industry | Biotechnology |
In the news
 |
10x Genomics, Inc. (TXG) Q4 2025 Earnings Call TranscriptFebruary 13 - SeekingAlpha |
 |
10X Genomics (NASDAQ:TXG) Posts Q4 Earnings Beat Amid Cautious 2026 OutlookFebruary 12 - ChartMill |
|
10x Genomics, Inc. (TXG) Presents at 44th Annual J.P. Morgan Healthcare Conference - SlideshowJanuary 12 - SeekingAlpha |
|
10x Genomics, Inc. (TXG) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 11 - SeekingAlpha |
Neuronal Subtype-Specific Ribosomal Protein mRNA Expression [Article]April 9 - Cshlp.org |
|
Venezuelan equine encephalitis virus infection causes chronic neurobehavioral outcomes, cellular remodeling, and hippocampal single-cell transcriptomic changesApril 8 - Plos.org |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '25 | 166M | 53M | 113M | -16M | -20M | 0.071 |
| Q3 '25 | 149M | 49M | 100M | -27M | -16M | -0.023 |
| Q2 '25 | 173M | 48M | 125M | 35M | 47M | 0.280 |
| Q1 '25 | 155M | 49M | 105M | -34M | -24M | -0.280 |
| Q4 '24 | 165M | 54M | 111M | -49M | -38M | -0.140 |
Insider Transactions View All
| Saxonov Serge filed to sell 1,172,273 shares at $19.5. March 25 '26 |
| Saxonov Serge filed to sell 1,177,273 shares at $19.1. March 25 '26 |
| Saxonov Serge filed to sell 1,203,667 shares at $23.2. March 4 '26 |
| Saxonov Serge filed to sell 1,205,527 shares at $22.7. March 4 '26 |
| Teichmann Sarah A. filed to sell 26,780 shares at $19.4. February 27 '26 |
Similar companies
Read more about 10X Genomics (TXG) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - 10X Genomics
The Market Cap of 10X Genomics is $2.94B.
Currently, the price of one share of 10X Genomics stock is $23.00.
The TXG stock price chart above provides a comprehensive visual representation of 10X Genomics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling 10X Genomics shares. Our platform offers an up-to-date TXG stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, 10X Genomics (TXG) does not offer dividends to its shareholders. Investors interested in 10X Genomics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of 10X Genomics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
